A chemiluminescent immunoassay for urinary thromboxane B2

Area of Science:

• Biochemistry
• Analytical Chemistry
• Pharmacology

Background:

• Thromboxane A2 (TXA2) and related prostaglandins possess vasoactive properties, driving research into drugs that modulate their levels.
• Urinary thromboxane B2 (TXB2) and its metabolite 2,3-dinor thromboxane B2 serve as in-vivo indicators of thromboxane production.
• Accurate measurement of urinary TXB2 is crucial for evaluating investigative drugs that reduce TXA2 and consequently TXB2 levels.

Purpose of the Study:

• To develop a simple, sensitive, non-radioisotopic assay for quantifying urinary TXB2.
• To assess the feasibility of using a chemiluminescent assay for measuring urinary 2,3-dinor TXB2.

Main Methods:

• Development of a non-radioisotopic chemiluminescent assay for urinary TXB2.
• Validation of the assay's sensitivity (down to 5 pg/ml).
• Comparison of the chemiluminescent assay with gas chromatography/mass spectrometry (GC/MS).

Main Results:

• The developed chemiluminescent assay demonstrated high sensitivity (5 pg/ml).
• The assay showed excellent correlation with GC/MS (r = 0.96), even without prior column chromatography.
• Feasibility was established for a chemiluminescent assay to measure urinary 2,3-dinor TXB2.

Conclusions:

• A novel, sensitive, and non-radioisotopic chemiluminescent assay for urinary TXB2 has been successfully developed.
• This assay provides a reliable tool for measuring thromboxane production in subjects undergoing drug treatments.
• The method offers a practical alternative to traditional methods for TXB2 and 2,3-dinor TXB2 analysis.